Image of hexagons overlapping in different sizes

Regulatory Considerations for Moving from Emergency Use Authorization to Biological License Application for U.S. Products

Home / Papers and Presentations / Resource
Image with text 'CMC Strategy Forum Advancing Biopharmaceutical Development China'

Speaker Presentation Levis Robin CBER FDA 2022
Regulatory Considerations for Moving from Emergency Use Authorization to Biological License Application for U.S. Products

Related Files